<DOC>
	<DOCNO>NCT00154193</DOCNO>
	<brief_summary>The main purpose study identify cyclosporine C2 level 12 month treatment , cyclosporine microemulsion dosage adjust base C0 cyclosporine blood sample , retrospectively correlate C2 level outcome ( renal function incidence acute rejection )</brief_summary>
	<brief_title>Nordic Study Cardiac Lung Transplantation : Outcome Relation Cyclosporine Microemulsion C2 Levels</brief_title>
	<detailed_description />
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Patients receive first heart bilateral single lung transplant Patients triple maintenance immunosuppressive therapy consist cyclosporine microemulsion , steroid mycophenolate mofetil ( MMF ) / entericcoated mycophenolate sodium ( ECMPS , ( azathioprine ) indicate . Multiorgan transplant previously transplant organ Patients need two cyclosporine microemulsion dosage per day Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Heart transplant , lung transplant , renal function , cyclosporine C2 Levels</keyword>
</DOC>